Investing Profile

Vincent Ossipow

InvestorVC
Partner at Omega Funds
omegafunds.comSwitzerland
Photo of Vincent Ossipow, Partner at Omega Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4974 CONNECTIONS
Hotmail Network
4974 CONNECTIONS
Georgetown University Network
175 CONNECTIONS
University of Geneva Network
17 CONNECTIONS
cb
Omega Funds Partner
$100K - $5.0M
$1.5M
5
CompanyStageDateRound SizeTotal Raised
Callio Therapeutics
Series AMar 2025$190M
$190M
Co-investors: Brian Matesic (Norwest Venture Partners), Daniel Estes (Frazier Life Sciences)
Aerium Therapeutics
Series AMar 2022
Co-investors: Stephen Knight (F-Prime Capital Partners), Michael Powell (Omega Funds)
FoRx Therapeutics
SeedApr 2020$11M
$110M
Co-investors: Vincent Brichard (EQT Group), Florian Müllershausen (Novartis Venture Fund), Therese Liechtenstein (MDC Ventures (formerly KBS Ventures)), Denis Patrick (Pfizer Venture Investments)
Andrew Alliance
Series CJun 2018$14M
Series BAug 2014
$14M
Postdoctoral Fellow National Cancer Institute (NCI)Present
Financial Analyst Pictet GroupPresent
Faculty Member Université de GenèvePresent
Investment Manager Sectoral Asset ManagementPresent
Member of the Board of Directors HotmailPresent
Chief Scientific Officer (CSO) HotmailPresent
Partner Private Equity Sectoral Asset ManagementPresent
Partner Omega FundsPresent
Partner at Omega Funds Omega FundsPresent
University of Geneva Doctor of Philosophy (Ph.D.) Molecular Biology
Georgetown University Certificate International Finance
Sign in with Google →
Sign in with Google →